article · Current Topics in Medicinal Chemistry
INTRODUCTION: Liver fibrosis is a critical disorder associated with elevated morbidity and mortality rates globally, leading to many organ dysfunctions. Thymol is a phenolic aromatic chemical extracted from thyme oil. It possesses biochemical, oxidative, anti-inflammatory, and anticancer properties. This results in its widespread applications across various domains, including cosmetics, medicine, and pharmacology. This study aims to assess the efficiency of thymol-loaded chitosan nanoparticles (CS-thymol NPs) in the bile duct ligation (BDL) model of liver fibrosis. METHODS: Thirty male Wister rats were divided into five groups: Sham, BLD, and cholestasis rats treated with chitosan NPs (60 mg/kg body weight, orally), thymol (30 mg/kg body weight, orally), and CS-thymol NPs (60 mg/kg body weight, orally). RESULTS: The administration of CS-thymol NPs markedly enhanced liver function, evidenced by reduced hepatic enzyme activity and elevated albumin level. Furthermore, CS-thymol NPs induced an elevation in glutathione and reduced catalase levels, and along with the reduction in malondialdehyde and nitric oxide production. Furthermore, CS-thymol NPs therapy diminished DNA damage in cholestatic rats and partially restored the normal architecture of hepatic tissues in these subjects. Immunohistochemistry analysis revealed a significant reduction in inflammation and apoptosis by decreasing levels of TNF-α and caspase-3 expression. DISCUSSION: The anticholestatic mechanisms of thymol may depend on its anti-inflammatory activity through the inhibition of TNF-α release, its antioxidative properties by decreasing MDA and NO levels while enhancing CAT and GSH, and its anti-apoptotic effects, likely associated with the down-regulation of activated caspase-3 and DNA damage. CONCLUSION: The incorporation of thymol into chitosan NPs boosts its antioxidant, antiinflammatory, and anti-apoptotic properties, thereby improving liver function and structure of cholestatic rats.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.2174/0115680266391085251022030252
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.